New class of drugs could help tackle treatment-resistant cancers
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies...
List view / Grid view
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies...
Stem cell-derived retinal cells need primary cilia to support the survival of light-sensing photoreceptors...
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial…
With access challenges even after successful but costly development programmes, the industry is under pressure to speed up the clinical development process and produce more for less. Adaptive trial designs, more collaborative working and data sharing could provide a solution in the area of cancer immunotherapy, says Jacqueline Karmel, principal…
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
Researchers have helped shed light on some of the underlying genetic causes of CHD as well as the long-term outlook for patients who carry these mutations...
A new technique for modelling leukaemia may aid drug discovery...
A three-pronged antibody has been found to protect from infection with two strains of SHIV, better than individual natural antibodies...
An antibody treatment has been found to reduce the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant COPD...
A network of hospitals have systematically collected biopsies from metastatic cancer patients in order to create a global database...
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...
An experimental immuno-oncology treatment will move into early phase clinical trials for patients with advanced solid tumours...
Scientists have made progress in the development of products that improve mitochondrial function...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...